This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

For more information on Affera and the Sphere-9 catheter, visit Medtronic.com. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's ...

The lawsuit was brought against Medtronic by New York resident Charles Riegel following the rupture of a Medtronic catheter in his coronary artery during heart surgery. He suffered severe injuries as ...

News, November 11, 2009 Alert Edwards Recalls Aortic Catheters Edwards's September ... News, September 16, 2009 Alert Medtronic CRT-D and ICD Advisory Medtronic Inc has issued a warning about ...

Medtronic highlighted results from its PULSED AF clinical trial, which demonstrated the catheter isolated pulmonary veins with an average energy delivery time of 30 seconds. The device is designed ...

Approved by the U.S. Food and Drug Administration (FDA) in November 2023, the Medtronic Symplicity Spyral ... inserts a single thin tube (known as a catheter) into the artery leading to the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system featuring the Sphere-9 Catheter. This innovative, all-in-one system ...

Medtronic plc, a global leader in healthcare technology, announced the United States Food and Drug Administration (FDA) has approval of the Affera Mapping and Ablation System with Sphere-9 catheter, ...

ablation catheter for treatment of persistent atrial fibrillation (AFib) and for RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter. With this approval, Medtronic is now the first ...

The Affera Mapping and Ablation System and Sphere-9 catheter also received CE Mark in March 2023 and was approved in Australia in September 2024. In October 2024, Medtronic announced the start of ...